U.S. Markets open in 7 hrs 40 mins

Atai Life Sciences N.V. (ATAI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.9700+0.0500 (+1.28%)
At close: 04:00PM EDT
4.1400 +0.17 (+4.28%)
After hours: 06:16PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.9200
Bid0.0000 x 4000
Ask0.0000 x 800
Day's Range3.9000 - 4.1437
52 Week Range3.0500 - 22.9100
Avg. Volume839,919
Market Cap636.383M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-3.9390
Earnings DateNov 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est26.31
  • GlobeNewswire

    atai Life Sciences Reports First Quarter 2022 Financial Results and Business Update

    – Strong execution across atai’s three strategic pillars: rapid acting pharmacological intervention, ongoing digital support and biomarker-driven precision mental health – Key milestones include first subject dosed in Phase 1 KUR-101, launch of drug discovery engine Invyxis, initiation of Psyber usability study in patients and COMPASS’ end of Phase 2 FDA meeting – Ended the first quarter with $335 million cash, maintaining atai’s position as a well-funded, leading mental health company Video int

  • Insider Monkey

    Cathie Wood’s Latest Portfolio: 10 New Stock Picks in 2022

    In this article we will discuss some new stock picks of Cathie Wood’s hedge fund. You can skip this part and go directly to see the top 5 New Stock Picks of Cathie Wood in 2022. Despite huge criticism and losses, Cathie Wood’s hedge fund ARK Investment continues to attract investors amid promises of future […]

  • GlobeNewswire

    CORRECTION - atai Life Sciences to Announce First Quarter 2022 Financial Results and Business Update

    NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- In a release issued yesterday under the headline "atai Life Sciences to Announce First-Quarter 2022 Financial Results" by atai Life Sciences N.V. (Nasdaq: ATAI), please note the first and second paragraphs, which contained statements referencing the 2022 IR financial results posting and executives on the video interview, as well as forward-looking statements, have been modified. The corrected release follows: atai Life Sciences N.V. (Nasdaq: ATAI) (“ata